advertisement

Tuberculosis

08 September 2010

Combining new drugs reduces TB

Papers four, five and six in The Lancet series on tuberculosis, looks at the effects of drugs, vaccines, biomarkers and diagnostics of TB.

Papers four, five and six in The Lancet series on Tuberculosis look at effect of drugs, vaccines, biomarkers and diagnostics with estimates that the combined effect of all four could reduce TB incidence by 94% by 2050.

The biomarkers aspects of the paper are covered by Professor Alimuddin Zumla, University College, London, and colleagues; while the diagnostics issues are covered by Dr Mark Perkins, Foundation for Innovative New Diagnostics, Geneva, Switzerland, and colleagues.

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.